News & Media

6 December 2024

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections a...

25 November 2024

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire bo...

18 November 2024

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the first auth...

4 November 2024

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction to...

30 October 2024

Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP...

9 October 2024

Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is di...

25 September 2024

Every year Stanford University publishes a list of highly cited scientists based on citation metrics from Scopus. The li...

16 September 2024

A breakthrough study, co-led by N2CR member A/Prof Raghav Sundar and includes Prof Jimmy So, A/Prof Yvonne Tay and Dr Yo...

6 September 2024

Multiple myeloma is a cancer of plasma cells, and its development and therapy resistance remain poorly understood. This ...